Finch Therapeutics Group Inc reports results for the quarter ended in June - Earnings Summary

Finch Therapeutics

10/08/2021 13:28

* Finch Therapeutics Group Inc  FNCH.OQ  reported a quarterly
adjusted loss of 32 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 28 cents per share.
* Revenue was $2.83 million​;  analysts expected zero. 
* Finch Therapeutics Group Inc's reported EPS for the quarter
was a loss of 32 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Finch Therapeutics Group Inc shares had fallen by 2.0% this
quarter.
* The company reported a quarterly loss of $15.17 million.
* Wall Street's median 12-month price target for Finch
Therapeutics Group Inc is $29.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 12:28 p.m.  ​All
figures in US dollars unless otherwise stated